Newly identified compounds appear effective against drug-resistant bacteria. The technique used to reveal them could uncover many more antibiotics, as well as help illuminate a previously hidden microbial world.

Using the novel platform could help pharmaceutical companies design longer lasting drugs.

Newly discovered weapons of bacterial self-defense take different approaches to achieving the same goal: preventing a virus from spreading through the bacterial population.

Open access, peer reviewed, and co-owned, the Journal of Human Immunity represents a new business model in scientific publishing.

Results presented at Conference on Retroviruses and Opportunistic Infections show that two broadly neutralizing antibodies can keep HIV suppressed for months.

New imaging reveals a built-in safeguard that allows B cell populations to rapidly expand in germinal centers without introducing deleterious mutations.

New study demonstrates how high-affinity B cells "bank" their best traits instead of rolling the dice and risking deleterious mutations, with implications for better vaccine design.

Jeffrey M. Friedman’s lab has discovered a mechanism to explain how leptin resistance works.

New insights could fine-tune this immunotherapy to avoid a common side effect without sacrificing efficacy.

It acts as a sort of molecular fumigator to battle phages and plasmids.